IP Library Granted Patent US 8,318,975
Granted Patent B2
US 8,318,975 · App. 12/766,178 · Granted Nov 27, 2012

Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof

Assignee: Ajinomoto Co., Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,318,975
App. No.
12/766,178
Granted
Nov 27, 2012
Kind
B2
Abstract

The present invention provides a method for producing a phenylalanine derivative(s) having a quinazolinedione ring of formula (5), including steps comprising of reacting an acylphenylalanine derivative(s) of formula (1) with a carbonyl group-introducing reagent(s) and a derivative(s) of anthranilic acid to form an asymmetric urea intermediate(s); making the asymmetric urea intermediate(s) into a quinazolinedione compound(s) of formula (4) in the presence of a base(s); and N-alkylating quinazolinedione ring amide of the obtained quinazolinedione compounds with N-alkylation agents. This production method is an industrially applicable method for producing phenylalanine derivatives having a quinazolinedione skeleton, which are compounds highly useful as drugs having α 4 integrin inhibiting activity. In the formulae (1) and (5), R1 represents a phenyl group having a substituent(s) and the like, R2 represents an alkyl group and the like, R3 represents a dialkylamino group and the like, and R4 represents an alkyl group and the like.

Claims (3)

1. Methylester of 5-dimethylamino-2-aminobenzoic acid according to the following formula (7)

or a salt thereof with a chemically acceptable acid.

2. A hydrochloride salt of methylester of 5-dimethylamino-2-aminobenzoic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: AJINOMOTO CO., INC.
To: EA PHARMA CO., LTD.
Reel/Frame 039094/0087 →
Priority Claims (1)
JP 2003-042560 · Feb 20, 2003 · national
Continuity (3)
Continuation 11207751 · Aug 22, 2005
Continuation PCTJP2004001982 · Feb 20, 2004
Related Publication 20100204505A1 · Aug 12, 2010